Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06832891 · ClinicalTrials.gov registry record
Patient Preferences in Empathetic Communication by AI vs Human Authorship
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 202
- Enrollment target
NCT06832891: Completed study, sponsored by Mayo Clinic.
NCT06832891 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 202 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06832891 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 202 participants
- Enrollment target
Study Summary
This study aims to evaluate whether patients have different preference patterns for empathetic communication through AI vs human-being when knowledge of authorship is known vs blinded.
Primary Outcome
Assessed by a brief survey: patients will be show two brief empathetic statements related to their serious illness diagnosis (Cancer), one generated by Artificial Intelligence (AI) and one generated by a human physician in palliative care who were both given the same writing instructions and generated their responses independently. Half of the surveys will label which statement is generated by human or AI unblinded group) and the other half will be blinded to statement authorship. Preference wil
Interventions
- OTHER Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 202 participants |
| Start Date | 2025-04-21 |
| Est. Completion | 2025-06-30 |
What the finished NCT06832891 record still lists
NCT06832891 is an observational study that tracks outcomes without assigning an intervention. The registered 202 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Survey is the first listed.
NCT06832891 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06832891 about?
NCT06832891 is a clinical study titled "Patient Preferences in Empathetic Communication by AI vs Human Authorship". This study aims to evaluate whether patients have different preference patterns for empathetic communication through AI vs human-being when knowledge of authorship is known vs blinded.
What is the current status of trial NCT06832891?
This trial is currently completed. The enrollment target is 202 participants. The study started on 2025-04-21. Estimated completion is 2025-06-30.
What interventions are being tested in trial NCT06832891?
The interventions under investigation include: Survey (OTHER).
Who is sponsoring clinical trial NCT06832891?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05272254 · 202 participants · Phase 2
Povidone Iodine Efficacy Study
- NCT05701280 · 202 participants · NA
Pilot/Pivotal Study of DBS+Rehab After Stroke
- NCT05932589 · 202 participants
Neurophysiologic Biomarkers in Rett Syndrome
- NCT06014931 · 202 participants · NA
Telehealth-enhanced Patient-oriented Recovery Trajectory After Intensive Care
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI